Large-scale testing (Phase 3)Ended earlyNCT02760602
What this trial is testing
Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease
Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 26
Showing 20 of 171 results